Data‑driven decisions are choices guided by systematic analysis of quantitative information, such as model predictions, experimental results, or real‑world evidence, rather than relying mainly on intuition or tradition. In AI‑enabled drug discovery, this phrase signals a shift toward using algorithmically generated insights to prioritise compounds and projects. Clinicians and managers should recognise it as both an opportunity and a governance challenge.